Get Live Data

IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production
Bradda Head Lithium exceeds targets, secures US$3 million royalty and moves closer to productionView Video
IntelliAM aiming for significant growth with £5 million Aquis IPO
IntelliAM aiming for significant growth with £5 million Aquis IPOView Video

Latest Share Chat

  2. Share Prices
  3. Smith & Nephew Share Price
  4. Smith & Nephew Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Smith & Nephew Information

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,054.00
Bid: 1,060.50
Ask: 1,061.00
Change: 67.80 (6.87%)
Spread: 0.50 (0.047%)
Open: 1,027.00
High: 1,068.00
Low: 1,027.00
Prev. Close: 986.20
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

8 Feb 2019 13:59

RNS Number : 5365P
Smith & Nephew Plc
08 February 2019
 

8 February 2019

 

Smith & Nephew plc (the "Company")

 

Commencement of Quarterly Buy Back Programme

 

The Company will now commence its Quarterly Buy Back Programme of 975,682 of its ordinary shares of US 20¢ each (the "Buy Back Programme") and has entered into an agreement with J.P. Morgan Securities plc ("JPMS") under which it has issued an irrevocable instruction to JPMS to manage the Buy Back Programme.

 

The Company intends to hold these shares in Treasury and then cancel them.

 

These shares were used in connection with employee share schemes in Quarter 4 2018.

 

The purpose of this Buy Back Programme is to reduce the share capital of the Company, in order to keep it broadly constant. The maximum pecuniary amount allocated to the Buy Back Programme is £16,000,000 and the maximum number of shares that will be purchased under the Buy Back Programme is 975,682. The Buy Back Programme will commence on 11 February 2019 and will end no later than 15 February 2019.

 

This announcement is made in accordance with Chapter 12 of the UKLA Listing Rules and Market Abuse Regulation 596/2014.

 

 

Susan Swabey

Company Secretary

Smith & Nephew plc

Tel: 01923 477216

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSSSAFDAFUSEIE
34567891011
Date   Source Headline
9th Apr 20207:00 amRNSSmith+Nephew appoints Anne-Francoise Nesmes as CFO
6th Apr 20209:00 amRNSAdditional Annual General Meeting update
1st Apr 202012:36 pmRNSTotal Voting Rights
1st Apr 20209:30 amRNSDirector/PDMR Shareholding
30th Mar 20207:01 amRNSAnnual General Meeting update
30th Mar 20207:00 amRNSStatement on COVID-19 impact
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20203:23 pmRNSDirector/PDMR Shareholding
24th Mar 20204:43 pmRNSSecond Price Monitoring Extn
24th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20204:38 pmRNSPrice Monitoring Extension
10th Mar 20205:32 pmRNSDirector/PDMR Shareholding
9th Mar 20205:06 pmRNSDirector/PDMR Shareholding
5th Mar 202012:55 pmRNSHolding(s) in Company
5th Mar 20207:01 amRNSDirectorate Change
5th Mar 20207:00 amRNSDirectorate Change
2nd Mar 20205:00 pmRNSAnnual Financial Report
2nd Mar 20203:46 pmRNSTransaction in Own Shares
2nd Mar 20201:46 pmRNSTotal Voting Rights
25th Feb 20206:20 pmRNSTransaction in Own Shares
24th Feb 20205:52 pmRNSTransaction in Own Shares
24th Feb 202011:12 amRNSDirector/PDMR Shareholding
21st Feb 20204:11 pmRNSDirector/PDMR Shareholding
21st Feb 202010:48 amRNSTransaction in Own Shares
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
7th Feb 20203:10 pmRNSDirector/PDMR Shareholding
6th Feb 20208:24 amRNSDirector Declaration
3rd Feb 20202:25 pmRNSBlock listing Interim Review
3rd Feb 202011:24 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSSmith+Nephew acquires Tusker Medical, Inc.
21st Jan 20203:00 pmRNSNotice of Results
16th Jan 20203:56 pmRNSDirector/PDMR Shareholding
2nd Jan 202010:34 amRNSTotal Voting Rights
2nd Dec 20194:34 pmRNSAdditional Listing
2nd Dec 201912:13 pmRNSTotal Voting Rights
20th Nov 20199:17 amRNSDirector/PDMR Shareholding
14th Nov 20199:17 amRNSDirector/PDMR Shareholding
12th Nov 20194:21 pmRNSTransaction in Own Shares
8th Nov 201912:54 pmRNSTransaction in Own Shares
8th Nov 20199:07 amRNSDirector/PDMR Shareholding
7th Nov 20195:33 pmRNSTransaction in Own Shares
6th Nov 20195:56 pmRNSTransaction in Own Shares
6th Nov 20193:05 pmRNSDirector/PDMR Shareholding
5th Nov 20196:13 pmRNSTransaction in Own Shares
4th Nov 20191:07 pmRNSDirector Declaration
4th Nov 201911:50 amRNSTransaction in Own Shares
34567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.